Javier
Rodríguez Rodríguez
Consultor Médico
Universitat de Barcelona
Barcelona, EspañaPublikationen in Zusammenarbeit mit Forschern von Universitat de Barcelona (1)
2018
-
Outcomes after neoadjuvant treatment with gemcitabine and erlotinib followed by gemcitabine–erlotinib and radiotherapy for resectable pancreatic cancer (GEMCAD 10-03 trial)
Cancer Chemotherapy and Pharmacology, Vol. 82, Núm. 6, pp. 935-943